The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

被引：10

作者：

Dai, Chia-Yen ^{[1
,2
]}

Fang, Tzu-Jung ^{[3
]}

Hung, Wei-Wen ^{[4
]}

Tsai, Hui-Ju ^{[2
,5
,6
]}

Tsai, Yi-Chun ^{[2
,7
,8
,9
,10
]}

机构：

[1] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung 807, Taiwan

[2] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 807, Taiwan

[3] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Kaohsiung 807, Taiwan

[4] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Kaohsiung 807, Taiwan

[5] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Family Med, Kaohsiung 801, Taiwan

[6] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung 807, Taiwan

[7] Kaohsiung Med Univ Hosp, Div Gen Med, Kaohsiung 807, Taiwan

[8] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung 807, Taiwan

[9] Kaohsiung Med Univ, Liquid Biopsy & Cohort Res Ctr, Kaohsiung 807, Taiwan

[10] Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Kaohsiung 807, Taiwan

来源：

BIOMEDICINES | 2022年 / 10卷 / 07期

关键词：

liver fibrosis; type 2 diabetes mellitus; NAFLD; fibroscan; TRANSIENT ELASTOGRAPHY; GLOBAL EPIDEMIOLOGY; PREVALENCE; STEATOHEPATITIS; PATHOGENESIS; MANAGEMENT; STEATOSIS; DIAGNOSIS; STIFFNESS; DELIVERY;

D O I：

10.3390/biomedicines10071487

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whether the impact of liver fibrosis is not fully realized in type 2 diabetes mellitus (T2D) patients with nonalcoholic fatty liver disease (NAFLD), and the factors affecting nonalcoholic steatohepatitis (NASH) or liver stiffness also remain unclear. The aim of this study was to evaluate the determinants of liver fibrosis and in T2D patients with NAFLD. Liver fibrosis and steatosis were measured using transient elastography (FibroScan). Of 226 T2D patients with NAFLD, 50 with liver fibrosis had higher body mass index, serum uric acid, triglyceride and glycated hemoglobin levels and lower high density lipoprotein levels than 176 without liver fibrosis. Multivariate analysis revealed that aging, obesity, sulfonylurea usage and high levels of AST increased the risk of liver fibrosis in T2D patients with NAFLD. Our findings provide useful information to clinical physicians for earlier detection of liver fibrosis in T2D patients with NAFLD and to prevent liver fibrosis through controlling these risk factors.

引用

页数：12

共 55 条

[41] Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease [J].

Takeshita, Yumie ;

Kanamori, Takehiro ;

Tanaka, Takeo ;

Kaikoi, Yuka ;

Kita, Yuki ;

Takata, Noboru ;

Iida, Noriho ;

Arai, Kuniaki ;

Yamashita, Tatsuya ;

Harada, Kenichi ;

Gabata, Toshifumi ;

Nakamura, Hiroyuki ;

Kaneko, Shuichi ;

Takamura, Toshinari .

DIABETES THERAPY, 2020, 11 (02) :549-560

[42] Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus [J].

Targher, Giovanni ;

Lonardo, Amedeo ;

Byrne, Christopher D. .

NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (02) :99-114

[43] Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis [J].

Tiniakos, Dina G. ;

Vos, Miriam B. ;

Brunt, Elizabeth M. .

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 :145-171

[44] Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease [J].

Tolman, Keith G. ;

Fonseca, Vivian ;

Dalpiaz, Anthony ;

Tan, Meng H. .

DIABETES CARE, 2007, 30 (03) :734-743

[45] Computational Modelling of Liver Metabolism and its Applications in Research and the Clinics [J].

Tomas, Tanja Cvitanovic ;

Moskon, Miha ;

Mraz, Miha ;

Rozman, Damjana .

ACTA CHIMICA SLOVENICA, 2018, 65 (02) :253-265

[46] Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan [J].

Tran Thi Khanh Tuong ;

Dang Khoa Tran ;

Pham Quang Thien Phu ;

Tong Nguyen Diem Hong ;

Thien Chu Dinh ;

Dinh Toi Chu .

DIAGNOSTICS, 2020, 10 (03)

[47] Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults [J].

Vernon, G. ;

Baranova, A. ;

Younossi, Z. M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) :274-285

[48] Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study [J].

Vilar-Gomez, Eduardo ;

Calzadilla-Bertot, Luis ;

Wong, Vincent Wai-Sun ;

Castellanos, Marlen ;

Aller-de la Fuente, Rocio ;

Metwally, Mayada ;

Eslam, Mohammed ;

Gonzalez-Fabian, Licet ;

Alvarez-Quinones Sanz, Maria ;

Felix Conde-Martin, Antonio ;

De Boer, Bastiaan ;

McLeod, Duncan ;

Chan, Anthony Wing Hung ;

Chalasani, Naga ;

George, Jacob ;

Adams, Leon A. ;

Romero-Gomez, Manuel .

GASTROENTEROLOGY, 2018, 155 (02) :443-+

[49] Type 2 diabetes and risk of hospital admission or death for chronic liver diseases [J].

Wild, Sarah H. ;

Morling, Joanne R. ;

McAllister, David A. ;

Kerssens, Jan ;

Fischbacher, Colin ;

Parkes, Julie ;

Roderick, Paul J. ;

Sattar, Naveed ;

Byrne, Christopher D. .

JOURNAL OF HEPATOLOGY, 2016, 64 (06) :1358-1364

[50] Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis [J].

Ye, Qing ;

Zou, Biyao ;

Yeo, Yee Hui ;

Li, Jie ;

Huang, Daniel Q. ;

Wu, Yuankai ;

Yang, Hongli ;

Liu, Chuanli ;

Kam, Leslie Y. ;

Tan, Xiang Xuan Eunice ;

Chien, Nicholas ;

Trinh, Sam ;

Henry, Linda ;

Stave, Christopher Donald ;

Hosaka, Tetsuya ;

Cheung, Ramsey C. ;

Nguyen, Mindie H. .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (08) :739-752

← 1 2 3 4 5 6 →